9 Biotechnology Trends Developing in 2023
Top Biotechnology Trends · 1. The Use of Next-Generation Computing Technology · 2. Increased Stakeholder Collaboration · 3. The Evolution of ...
future of the clinical trial
As noted, machine learning technology also holds promise for the <anchor>future of the clinical trial</anchor>. Biotech companies can quickly analyze data from current trials to predict the effectiveness of treatments down to a molecular level; they can also revisit data from previous trials to see if anything may have been missed, or if there may be new or different uses for an existing drug.
10 Professionals Predict the Future of Clinical Trials - Xtalks
10 Professionals Predict the Future of Clinical Trials - Xtalks

Monday, September 16, 2024 @ 10am EDT: [Shifting Ophthalmology Retina Market: Proactive Planning for Late-Stage Clinical Success](https://xtalks.com/webinars/shifting-ophthalmology-retina-market-proactive-planning-for-late-stage-clinical-success/)

X

[Skip to content](#content)

- [LOGIN](https://xtalks.com/login/)
- [JOIN](https://xtalks.com/register/)

[![Xtalks](https://xtalks.com/wp-content/themes/xtalks/assets/img/xtalks_logo.png)](https://xtalks.com/)

- [Webinars](https://xtalks.com/webinars/)
- [Industries](https://xtalks.com/webinars/)
  - [Food](https://xtalks.com/food-industry/)
  - [Medical Devices](https://xtalks.com/medical-devices/)
  - [Healthcare](https://xtalks.com/healthcare/)
  - [Life Sciences](https://xtalks.com/life-sciences/)
    - [Peer Circles](https://xtalks.com/peer-circles/)
- [Editorial](https://xtalks.com/vitals/)
  - [All Vitals](https://xtalks.com/vitals/)
  - [News](https://xtalks.com/category/news/)
  - [Blogs](https://xtalks.com/category/blogs/)
  - [Videos](https://xtalks.com/category/videos/)
  - [Quizzes & Polls](https://xtalks.com/category/quizzes-polls/)
  - [Life Science Spotlight](https://xtalks.com/category/spotlight/)
  - [Life Science Podcast](https://xtalks.com/category/life-science-podcast/)
  - [Xtalks Clinical Edge](https://clinicaledge.xtalks.com/magazine/resource-hub/)
  - [Food Industry Spotlight](https://xtalks.com/category/food-spotlight/)
  - [Food Industry Podcast](https://xtalks.com/category/food-industry-podcast/)
- [Industry Jobs](https://xtalks.com/life-science-jobs/)
  - [Search Jobs](https://xtalks.com/job/)
  - [Talent Acquisition & Branding Bundle](https://xtalks.com/xtalks-talent-acquisition-branding-bundle-position-your-organization-to-attract-elite-talent/)
  - [Post Job](https://xtalks.com/create-job/)
  - [Career Insights](https://xtalks.com/category/blogs/career-insights-blogs/)
- [Why host a webinar?](https://xtalks.com/why-host-a-webinar/)
  - [Contact Us to Host Your Webinars](https://xtalks.com/host-a-webinar/)
  - [Learn More](https://xtalks.com/why-host-a-webinar/)
  - [Webinar Production & Marketing Tips](https://xtalks.com/category/blogs/webinar-production-tips/)
- [About Us](https://xtalks.com/about/)
  - [Frequently Asked Questions](https://xtalks.com/frequently-asked-questions/)
  - [Team](https://xtalks.com/team/)
  - [Join Xtalks](https://xtalks.com/register/)
- [Contact](https://xtalks.com/contact/)

- [Webinars](https://xtalks.com/webinars/)
- [Industries](https://xtalks.com/webinars/)
  - [Food](https://xtalks.com/food-industry/)
  - [Medical Devices](https://xtalks.com/medical-devices/)
  - [Healthcare](https://xtalks.com/healthcare/)
  - [Life Sciences](https://xtalks.com/life-sciences/)
    - [Peer Circles](https://xtalks.com/peer-circles/)
- [Editorial](https://xtalks.com/vitals/)
  - [All Vitals](https://xtalks.com/vitals/)
  - [News](https://xtalks.com/category/news/)
  - [Blogs](https://xtalks.com/category/blogs/)
  - [Videos](https://xtalks.com/category/videos/)
  - [Quizzes & Polls](https://xtalks.com/category/quizzes-polls/)
  - [Life Science Spotlight](https://xtalks.com/category/spotlight/)
  - [Life Science Podcast](https://xtalks.com/category/life-science-podcast/)
  - [Xtalks Clinical Edge](https://clinicaledge.xtalks.com/magazine/resource-hub/)
  - [Food Industry Spotlight](https://xtalks.com/category/food-spotlight/)
  - [Food Industry Podcast](https://xtalks.com/category/food-industry-podcast/)
- [Industry Jobs](https://xtalks.com/life-science-jobs/)
  - [Search Jobs](https://xtalks.com/job/)
  - [Talent Acquisition & Branding Bundle](https://xtalks.com/xtalks-talent-acquisition-branding-bundle-position-your-organization-to-attract-elite-talent/)
  - [Post Job](https://xtalks.com/create-job/)
  - [Career Insights](https://xtalks.com/category/blogs/career-insights-blogs/)
- [Why host a webinar?](https://xtalks.com/why-host-a-webinar/)
  - [Contact Us to Host Your Webinars](https://xtalks.com/host-a-webinar/)
  - [Learn More](https://xtalks.com/why-host-a-webinar/)
  - [Webinar Production & Marketing Tips](https://xtalks.com/category/blogs/webinar-production-tips/)
- [About Us](https://xtalks.com/about/)
  - [Frequently Asked Questions](https://xtalks.com/frequently-asked-questions/)
  - [Team](https://xtalks.com/team/)
  - [Join Xtalks](https://xtalks.com/register/)
- [Contact](https://xtalks.com/contact/)

# 10 Professionals Predict the Future of Clinical Trials

**Posted on:** July 2, 2019 in [Life Science Videos](https://xtalks.com/category/videos/life-science-videos/) \| [Life Science Blogs](https://xtalks.com/category/blogs/life-science-blogs/) \| [Blogs](https://xtalks.com/category/blogs/)

**By:** [Tegan Versolatto](https://xtalks.com/author/tversolatto/ "Posts by Tegan Versolatto")

### Share this:

- [Click to share on LinkedIn (Opens in new window)](https://xtalks.com/10-professionals-predict-the-future-of-clinical-trials-1967/?share=linkedin "Click to share on LinkedIn")
- [Click to share on Facebook (Opens in new window)](https://xtalks.com/10-professionals-predict-the-future-of-clinical-trials-1967/?share=facebook "Click to share on Facebook")
- [Click to share on X (Opens in new window)](https://xtalks.com/10-professionals-predict-the-future-of-clinical-trials-1967/?share=x "Click to share on X")
- [Click to share on Reddit (Opens in new window)](https://xtalks.com/10-professionals-predict-the-future-of-clinical-trials-1967/?share=reddit "Click to share on Reddit")
- [Click to email a link to a friend (Opens in new window)](/cdn-cgi/l/email-protection#9aa5e9eff8f0fff9eea7bfafd8c9f2fbe8fffebfa8aacaf5e9eebfafdebfa8aaabaabfa8aacae8f5fcffe9e9f3f5f4fbf6e9bfa8aacae8fffef3f9eebfa8aaeef2ffbfa8aadcefeeefe8ffbfa8aaf5fcbfa8aad9f6f3f4f3f9fbf6bfa8aacee8f3fbf6e9bcf8f5fee3a7f2eeeeeae9bfa9dbbfa8dcbfa8dce2eefbf6f1e9b4f9f5f7bfa8dcabaab7eae8f5fcffe9e9f3f5f4fbf6e9b7eae8fffef3f9eeb7eef2ffb7fcefeeefe8ffb7f5fcb7f9f6f3f4f3f9fbf6b7eee8f3fbf6e9b7aba3acadbfa8dcbce9f2fbe8ffa7fff7fbf3f6 "Click to email a link to a friend")

[Subscribe](#subscribe)

![10 Professionals Predict the Future of Clinical Trials](https://i0.wp.com/xtalks.com/wp-content/uploads/2019/06/65392520_461288401300717_8462879666858885120_n.jpg?fit=892%2C669&ssl=1)

Xtalks journalist Candice Tang interviews Imran Chaudhri, Chief Architect for Healthcare and Life Sciences for MarkLogic at DIA 2019.

Developing new drugs is a slow, costly and labor-intensive process, but cutting-edge technologies offer the promise of streamlining the process in a way that’s never been done before. The pharma industry is also approaching clinical trials in a more thoughtful and connected way, putting a greater emphasis on the goals and desires of the patients and families involved.

As the healthcare industry approaches a new age of trials, _Xtalks_ spoke with 10 professionals gathered at the Drug Information Association (DIA) Global Annual Meeting 2019 in San Diego, CA, to get their take on what the future of clinical trials holds. Here’s what they had to say:

**Michael Kleppinger, PhD, MBA**, Executive Vice President of Clinical Market Development, [Syneos Health](https://www.syneoshealth.com/)

“The future of clinical trials obviously has to be directly correlated to increasing patient care, migrating from a standard of care to a better service level for our patients irrespective of the therapeutic application.”

“Data obviously is very prevalent in our industry and becoming much more accessible to all of the different constituents within the industry. It’s all about how we convert that data to actionable intelligence. As you can see here at DIA this week, there’s a lot of focus and companies that are working to bring those insights to both patients and clinicians which is important to us all.”

> Post shoot selfie. ⁦ [@Xtalks](https://twitter.com/Xtalks?ref_src=twsrc%5Etfw) ⁩ reporters visited with Mike Kleppinger to discuss the future of clinical trials. [#DIA2019](https://twitter.com/hashtag/DIA2019?src=hash&ref_src=twsrc%5Etfw) [pic.twitter.com/tX0IqOxiYO](https://t.co/tX0IqOxiYO)
>
> — Syneos Health (@SyneosHealth) [June 25, 2019](https://twitter.com/SyneosHealth/status/1143562263879569410?ref_src=twsrc%5Etfw)

**Bryan Clayton**, Vice President of Strategic Solutions, [YPrime](https://www.yprime.com/)

“Clinical trials are getting more and more complex. We’re seeing things like master protocols, adaptive trial design, basket design… the more we see these types of trials, the more we have to allow our technology to support them. What we’ve seen is that simple technology needs to support complex trial designs, and that’s where I think the industry will continue to go.”

**Lisa Dilworth**, Vice President of Rare and Orphan Disease Drug Development, [Synteract](https://www.synteract.com/)

“I think the future of clinical trials is really exciting right now, it’s going to be a lot of engagement with multiple stakeholders. We’re pulling in patients earlier than we ever have to make sure that they have the endpoints that they want and making sure we’re capturing what’s meaningful to patients. That’s happening a lot sooner, and it’s happening across all different drug development programs now.”

“We’re also working closely with regulators around the globe to make sure that we are all aligned and that we are developing programs that can be successful and meaningful.”

**Janine Jones, MBA,** Clinical Solutions Specialist, [BioClinica](https://www.bioclinica.com/)

“There’s a lot of competition in the arena which breeds a lot of success that’s upcoming for the clinical trial world, especially electronically. In my job, demo our software offerings and one of the things that the clinical trial world needs is interoperability, instant access to data no matter where you are in the world, flexibility of platforms and an electronic platform that makes it easy for clinicians, investigators, sponsors to do their jobs.”

> Meet the Bioclinica team at DIA Booth 1831. [#DIA2019](https://twitter.com/hashtag/DIA2019?src=hash&ref_src=twsrc%5Etfw) [https://t.co/pvvdiqJz32](https://t.co/pvvdiqJz32) [pic.twitter.com/tx4PLDIrMm](https://t.co/tx4PLDIrMm)
>
> — Bioclinica (@bioclinica) [June 24, 2019](https://twitter.com/bioclinica/status/1143247571697188865?ref_src=twsrc%5Etfw)

**Ken Light**, Executive Vice President of Corporate Strategy, [OmniComm Systems](https://www.omnicomm.com/)

“There’s a great deal of change and transformation going on right now in clinical trials as organizations try to become more effective and efficient. The changes are both in the way the business runs clinical trials and in the technology.”

“From a business perspective, organizations are spending a lot more money and investment in late-phase clinical trials. They’re basically trying to take the drugs that they’ve already brought to market and find new uses for those drugs, new indications and do safety profiling on those drugs. Within late-stage, you see things like risk-based monitoring and better approaches for monitoring of the data. We see a big focus on real-world data and real-world evidence pulling data in from genomic databases, from pharmacy databases, from clinical systems, from electronic health record systems, all to try and find meaningful value out of the drugs and the capabilities that exist today.”

“Another thing is virtual trials. There’s a whole push to try to expand the potential patient population and make clinical trials available to everybody including people that don’t have easy access to a clinical site.”

**Joe Ehrline, MBA**, Vice President of Sales, [Saama Technologies](https://www.saama.com/)

“My personal take on the future of clinical trials is on harnessing the data that is out there in clinical trials. Right now, so many companies are struggling with how to incorporate all this data from disparate systems and be able to use that to make business decisions. If you think about it, if you’re only getting partial data, be it from a CRO or EDC system or CTMS system or your financial systems or wherever that data is housed and sitting, how are you able to make informed decisions on partial data? In my mind, it’s like trying to throw darts with a blindfold on. These are decisions that are going to impact the outcome of your trials, it’s going to impact drug development and ultimately it’s going to impact us bringing therapies in need to the patients that are out there.”

**Patrick Hughes**, Chief Commercial Officer, [CluePoints](https://cluepoints.com/)

“What we’re seeing is the industry is much more amenable now to looking at data in different ways to enable different decisions to be made in a timely manner. What we’re going to see in the future is a lot more decision-making and knowledge based on the types of data analytics and data acquisitions that’s being undertaken.”

“But how the data is collected and ingested into systems like CluePoints to do analysis, we figure that’s going to change an awful lot in the future as well. There’s going to be data acquired from Fitbits, from devices, iWatches, all streaming into databases. The analytics are going to be a big part of how clinical trials are run in the future.”

> “What we’re going to see in the future is a lot more decision making and knowledge based upon types of data analytics and data acquisition that’s being undertaken,” says [@CluePoints](https://twitter.com/CluePoints?ref_src=twsrc%5Etfw)’ Patrick Hughes on the future of [#clinicaltrials](https://twitter.com/hashtag/clinicaltrials?src=hash&ref_src=twsrc%5Etfw) at [#DIA2019](https://twitter.com/hashtag/DIA2019?src=hash&ref_src=twsrc%5Etfw) [pic.twitter.com/UiY5yWpZ2K](https://t.co/UiY5yWpZ2K)
>
> — Xtalks Webinars (@Xtalks) [June 24, 2019](https://twitter.com/Xtalks/status/1143256067578593280?ref_src=twsrc%5Etfw)

**Sarah Ikard,** **MBA,** Senior Director, Business Development, [ICON plc](https://www.iconplc.com/)

“I think the future of clinical trials is really patient-focused. We are doing a lot of stuff with wearables and tracking patient data outside of the clinics. So, when they go home and use the product it’s tracking how the product is working and if they’re feeling better. I think that’s a big focus area right now.”

**Mike Nolte,** **MBA,** Chief Executive Officer, [Signant Health](https://signanthealth.com/)

“It’s going to be largely a fairly slow evolution towards broader participation of using technology as a lever. There’s a lot of buzz in the industry around siteless trials, or hybrid trials, or virtual trials. I think that progression will be relatively slow, but I do think that through technology, through video interaction, through devices collecting data, through the ability to provide services to somebody outside of a traditional site creates the opportunity for more people to potentially have access to life-changing research, but also creates an economic benefit for the sponsors that are running clinical research in the first place.”

**Imran Chaudhri**, Chief Architect for Healthcare and Life Sciences, [MarkLogic](https://www.marklogic.com/)

“Clinical trials are evolving in a lot of interesting ways. One is that clinical trials used to be very manual, very intense on the paperwork and administrative process of the system, and a lot of clinical trials had to be developed very specifically for the drug or disease of interest. These days, you can start combining physical clinical trials with virtual clinical trials, so being able to do retrospective studies on clinical data that’s been gathered over the years and combine that with your real clinical trials to get better insights. You can also take the data that you’re bringing in and run it through machine learning algorithms to get projections of predictions of how well certain molecules will work, as well as predictions on toxicology and how effective or ineffective the various treatments will be.

* * *

As the drug industry continues to advance its efforts to modernize clinical trials through new methods, regulations and technologies, sharing knowledge across the industry about what works and what doesn’t will be paramount in the future success of clinical trial execution.

**Keywords:**

- [Clinical Trials](https://xtalks.com/tag/clinical-trials/ "Clinical Trials")
, - [Drug Development](https://xtalks.com/tag/drug-development/ "Drug Development")
, - [Instagram Posts](https://xtalks.com/tag/ig-posts/ "Instagram Posts")
, - [DIA 2019](https://xtalks.com/tag/dia-2019/ "DIA 2019")

* * *

### Related Vitals

[**3 Strategies for Encouraging Inclusion of Minority Patients in MS Clinical Trials**](https://xtalks.com/3-strategies-for-encouraging-inclusion-of-minority-patients-in-ms-clinical-trials-1711/)

[![](https://xtalks.com/wp-content/uploads/2019/01/Diversity-People.jpg)](https://xtalks.com/3-strategies-for-encouraging-inclusion-of-minority-patients-in-ms-clinical-trials-1711/)

[News](https://xtalks.com/category/news/) January 7, 2019

[**AbbVie’s Anti-Tau Antibody Enters Phase II Clinical Trials for Alzheimer’s Disease**](https://xtalks.com/antibody-clinical-trials-alzheimers-disease-637/)

[![Alzheimer's disease](https://xtalks.com/wp-content/uploads/2017/02/hnvBmCe.jpg)](https://xtalks.com/antibody-clinical-trials-alzheimers-disease-637/)

[News](https://xtalks.com/category/news/) January 26, 2017

[**Addressing The Challenges Associated With Site Selection For Clinical Trials**](https://xtalks.com/site-selection-for-clinical-trials/)

[![](https://xtalks.com/wp-content/uploads/2017/01/clinical-trials-600-2.jpg)](https://xtalks.com/site-selection-for-clinical-trials/)

[Blogs](https://xtalks.com/category/blogs/) April 22, 2016

[**5 Ways To Increase Patient-Centricity In Your Clinical Trial Operations**](https://xtalks.com/patient-centricity-in-your-clinical-trial/)

[![](https://xtalks.com/wp-content/uploads/2016/02/Patient-Centricity-thumbnail.jpg)](https://xtalks.com/patient-centricity-in-your-clinical-trial/)

[Blogs](https://xtalks.com/category/blogs/) February 24, 2016

[**Address Your Challenges in Streamlining Clinical Testing Across Global Clinical Trials**](https://xtalks.com/editoreditoreditorclinical-testing/)

[![](https://xtalks.com/wp-content/uploads/2017/01/Guest-post-picture.png)](https://xtalks.com/editoreditoreditorclinical-testing/)

[Life Science Blogs](https://xtalks.com/category/blogs/life-science-blogs/) June 30, 2015

* * *

### Related Webinars

October 24, 2024 [**Dosimetry in clinical trials**](https://xtalks.com/webinars/dosimetry-in-clinical-trials/)

[![](https://xtalks.com/wp-content/uploads/2024/09/X_Talks_Banner_1600x400px.jpg)](https://xtalks.com/webinars/dosimetry-in-clinical-trials/)

![](https://i0.wp.com/xtalks.com/wp-content/uploads/2023/03/ICON-Positive-logo-PNG.png?fit=592%2C161&ssl=1)

October 29, 2024 [**Expanding CAR T Beyond Oncology: Medical, Operational & Practical Considerations**](https://xtalks.com/webinars/expanding-car-t-beyond-oncology-medical-operational-practical-considerations/)

[![](https://xtalks.com/wp-content/uploads/2024/09/20230418-ONCO-CAR-T-Webinar-Header-OPT-1.jpg)](https://xtalks.com/webinars/expanding-car-t-beyond-oncology-medical-operational-practical-considerations/)

![](https://i0.wp.com/xtalks.com/wp-content/uploads/2023/09/Worldwide_logo_NEW.png?fit=700%2C202&ssl=1)

October 22, 2024 [**Embracing a Culture of Quality: Establishing and Maintaining Effective CRO Oversight**](https://xtalks.com/webinars/embracing-a-culture-of-quality-establishing-and-maintaining-effective-cro-oversight/)

[![Oct 22 Webinar Banner](https://xtalks.com/wp-content/uploads/2024/09/Oct-22-Webinar-Banner.png)](https://xtalks.com/webinars/embracing-a-culture-of-quality-establishing-and-maintaining-effective-cro-oversight/)

![](https://i0.wp.com/xtalks.com/wp-content/uploads/2020/03/PremierResearch_logo-e1600783005503.jpg?fit=299%2C104&ssl=1)

October 30, 2024 [**Accelerating Psychiatry Clinical Trials Through a Patient-Centric Approach: Real Patients, Real Outcomes**](https://xtalks.com/webinars/accelerating-psychiatry-clinical-trials-through-a-patient-centric-approach-real-patients-real-outcomes/)

[![Psych Webinar 2024 - Hero Image](https://xtalks.com/wp-content/uploads/2024/09/Psych-Webinar-2024-Hero-Image.jpg)](https://xtalks.com/webinars/accelerating-psychiatry-clinical-trials-through-a-patient-centric-approach-real-patients-real-outcomes/)

![](https://i0.wp.com/xtalks.com/wp-content/uploads/2023/10/Medpace_FullColor1.png?fit=2101%2C319&ssl=1)

October 25, 2024 [**How Decentralized and Rapid NGS Testing Can Overcome Challenges in Oncology Trials**](https://xtalks.com/webinars/how-decentralized-and-rapid-ngs-testing-can-overcome-challenges-in-oncology-trials/)

[![](https://xtalks.com/wp-content/uploads/2024/09/PPDKarenS_Oct25_HeroImage.jpg)](https://xtalks.com/webinars/how-decentralized-and-rapid-ngs-testing-can-overcome-challenges-in-oncology-trials/)

![](https://i0.wp.com/xtalks.com/wp-content/uploads/2024/07/ThermoFisherScientific_Logo.jpg?fit=1590%2C341&ssl=1)

* * *

### Join or login to leave a comment

[JOIN](https://xtalks.com/register) [LOGIN](https://xtalks.com/login?redirect_to=https%3A%2F%2Fxtalks.com%2F10-professionals-predict-the-future-of-clinical-trials-1967%2F)

## Subscribe to our newsletters

Not a member yet? Sign up for our newsletters and receive webinars, vitals, and updates for your topic of choice

- Preferences


- Xtalks Vitals
- Vitals Life Science
- Vitals Food Industry
- Vitals Medical Devices
- Vitals Webinar Production Tips

- First Name\*

- Last Name\*

- Country\*

- Email\*

- CAPTCHA


Please review our privacy policy and understand that we may occasionally inform you of related Xtalks content if you click subscribe. You may unsubscribe at anytime.

##### Sign up for our newsletters and receive webinars, vitals and updates for your topic of choice.

- Preferences


- Xtalks Vitals
- Vitals Life Science
- Vitals Food Industry
- Vitals Medical Devices
- Vitals Webinar Production Tips

- First Name\*

- Last Name\*

- Country\*

- Email\*

- CAPTCHA


Please review our privacy policy and understand that we may occasionally inform you of similar content if you press submit to subscribe to a newsletter. You may unsubscribe at anytime.

## Webinars

- [All Webinars](https://xtalks.com/webinars/)
- [Host a Webinar](https://xtalks.com/host-a-webinar/)
- [Medical Devices](https://xtalks.com/medical-devices/)
- [Food Industry](https://xtalks.com/food-industry/)
- [Life Sciences](https://xtalks.com/life-sciences/)

## Vitals

- [News](https://xtalks.com/category/news/)
- [Blogs](https://xtalks.com/category/blogs/)
- [Videos](https://xtalks.com/category/videos/)
- [Quizzes & Polls](https://xtalks.com/category/quizzes-polls/)

## Industry Jobs

- [Career Insights Blogs](https://xtalks.com/category/blogs/career-insights-blogs/)
- [Post a Job](https://xtalks.com/create-job/)
- [Search Jobs](https://xtalks.com/job)

## About

- [About Us](https://xtalks.com/about/)
- [FAQ](https://xtalks.com/frequently-asked-questions/)
- [Meet the Team](https://xtalks.com/team/)
- [Contact](https://xtalks.com/contact/)
- [Privacy Policy](https://xtalks.com/privacy-policy/)
- [Terms of Use](https://xtalks.com/terms-of-use/)

## My Xtalks

- [Login](https://xtalks.com/login/)
- [My Profile](https://xtalks.com/my-profile/)
- [Edit Profile](https://xtalks.com/my-profile/edit-profile/)
- [Join Xtalks](https://xtalks.com/register/)
- [Xtalks Peer Circles](https://xtalks.com/peer-circles/)
- Back To Top

### Login

**Already have an account at Xtalks? Login with:**

[Facebook](https://xtalks.com/wp-login.php?wpe-login=true&action=wordpress_social_authenticate&mode=login&provider=Facebook&redirect_to=https%3A%2F%2Fxtalks.com%2F10-professionals-predict-the-future-of-clinical-trials-1967%2F "First agree with terms & policy") [LinkedIn](https://xtalks.com/wp-login.php?wpe-login=true&action=wordpress_social_authenticate&mode=login&provider=LinkedIn&redirect_to=https%3A%2F%2Fxtalks.com%2F10-professionals-predict-the-future-of-clinical-trials-1967%2F "First agree with terms & policy")

Or

Username or Email Address

Password

[Lost Password?](https://xtalks.com/wp-login.php?action=lostpassword)

Remember Me

Don't have an account?Join

### Join

Create an account for access to webinars, jobs, news, blogs, discussions and more. Join thousands of other professionals from life science, medical device and food industries.

**Create an account using**

[Facebook](https://xtalks.com/wp-login.php?wpe-login=true&action=wordpress_social_authenticate&mode=login&provider=Facebook&redirect_to=https%3A%2F%2Fxtalks.com%2F10-professionals-predict-the-future-of-clinical-trials-1967%2F "First agree with terms & policy") [LinkedIn](https://xtalks.com/wp-login.php?wpe-login=true&action=wordpress_social_authenticate&mode=login&provider=LinkedIn&redirect_to=https%3A%2F%2Fxtalks.com%2F10-professionals-predict-the-future-of-clinical-trials-1967%2F "First agree with terms & policy")

Or

Create an Account Using Your Email

- Username\*

- First Name\*

- Last Name\*

- Email\*

- \*


- You read and agreed to our [privacy policy](https://stagingxtalks.wpengine.com/privacy-policy/)

- CAPTCHA


Have an account? Login Here

#### To create an account, you will need to agree to the privacy policy and terms of use by clicking the agree button at the bottom of this form.

Jump to bottom

### Privacy Policy

This privacy policy describes the privacy practices for www.Xtalks.com (hereafter referred to as “the Site”). Citizens of the UK and EU should refer to [EU and UK – PRIVACY POLICY – HONEYCOMB WORLDWIDE INC.](#EUUK) All users of the Site should read this privacy policy in conjunction with the Site’s [**TERMS OF USE**](#TERMS). The Site is owned and operated by Honeycomb Worldwide Inc. (hereafter referred to as “Honeycomb”, “we”, “us” or “our”).

By using the Site, you agree to be bound by the Site’s Terms of Use and accept our Privacy Policy. Please note that our Privacy Policy and Terms of Use may be updated or modified at any time without notice and your continued use of the Site will indicate your acceptance of the revised terms.

This privacy notice applies solely to information collected by the Site. It will notify you of the following:

- What personally identifiable information is collected from you through the Site, how it is used and with whom it may be shared
- What choices are available to you regarding the use of your data
- The security procedures in place to protect the misuse of your information
- How you can correct any inaccuracies in the information

**Information Collection and Use**

Our Site uses cookies and/or other technologies. We may use cookies to help identify user preferences and estimate audience size. If you do not wish to receive cookies, you may change the settings on your Internet browser to alert you when a cookie is sent to your computer. You may then decide whether to accept it. Not accepting cookies may result in the reduced functionality of certain areas of the Site.

Our Site may also record clickstream data. Clickstream is a virtual breadcrumb trail that a user leaves behind while browsing. We may record paths you have taken (e.g. sections or stories clicked and the order in which it is done) and use this information to provide customized content. Clickstream data is not retained after your visit to our Site and does not identify you specifically.

When browsing the Site, we will collect your IP address along with information from networks collected before and after you visit the Site. Aggregated user data may be used to analyze audience demographics and user information. Aggregated user data may be shared with third parties.

We may collect personally identifiable information, which may include your name, job title, organization, email address, mailing address and telephone number. This information is primarily required to deliver our services to you. You may be required to provide personally identifiable information to:

- Access content on the Site
- Participate in, or contribute to, discussion forums, polls, quizzes and blogs
- Register for newsletters, webinars and other virtual events
- Setup your “My Profile” page that will provide you with one-click access when registering for virtual events and enable you to better customize your user experience

By entering your contact information on the Site and clicking “Join”, you agree to receive emails from us.

**Third Party Use of Information**

By entering your contact information to register for a webinar and clicking “Register”, you agree to permit us to share your contact information with third parties.

When you register for live or archived webinars, virtual events or other content (e.g. white papers) developed in conjunction with or by our partners, sponsors or other third party affiliates, we may share your contact information with these third parties. We may also share any additional information you supply during the event registration process or during your participation in an event (e.g. as polling data, messaging, score cards, surveys and other feedback) with the partners, sponsors or co-hosts of the event.

By entering your contact information in a poll or quiz, you agree that the associated information you supply may be shared with third parties by us.

By registering for webinars, other events or other content developed by or sponsored by our partners, you agree that your contact information may be shared with our partners as outlined above. Our partners have signed agreements binding them to abide by the applicable laws in their use of the information provided to them by us. Our partners are prohibited from sharing contact information provided by us with any third parties or agents outside their organization. For further clarification on their use of this information, you should also refer to the privacy policies of the partners associated with the content you wish to access.

Our partners may contact you after you have registered for access to the content or events on our Site that they have helped develop or have sponsored. By registering for access to this content, you agree to be contacted by our partners about relevant offers, services, initiatives and/or developments.

By participating in discussion forums on the Site, you understand that the information may be viewed and collected by others.

If you provide a testimonial or commentary about Honeycomb, its services or the services of its partners, you agree that we may use these testimonials or comments in our marketing literature both on and off the Site.

**Opting Out**

You may do any of the following at any time by contacting us via the email address or phone number provided on our Site:

- Opt out of future contacts from us
- See what data we have about you, if any
- Change or correct any data we have about you
- Amend or update your information via your “My Profile” page
- Ask us to delete any data we have about you
- Express any concern you have about our use of your data

**Security**

We take precautions to protect your information. When you submit sensitive information on our Site, your information is protected both online and offline. We use encryption to protect sensitive information transmitted online and we protect your information offline. Only our employees who need your information to perform a specific task (for example, customer service or marketing) are granted access to personally identifiable information. The computers and servers in which we store personally identifiable information are kept in a secure environment.

If you feel that we are not abiding by this privacy policy, please contact us immediately at 416- 977-6555 or [\[email protected\]](/cdn-cgi/l/email-protection)

### **EU and UK – PRIVACY POLICY – HONEYCOMB WORLDWIDE INC.**

01. [Welcome](#wel)
02. [Who we are](#who)
03. [Our EU and UK Representatives](#oureu)
04. [How to Contact Us](#howto1)
05. [What personal data we collect](#whatpersonal)
06. [Data Accuracy](#dataacc)
07. [How We Collect Your Personal Data](#howwe)
08. [Why We Use Your Personal Data](#whywe)
09. [Your Rights](#yourright)
10. [How to exercise your rights](#howtoexer)
11. [How long we hold your personal data](#howlong)
12. [Who do we share your personal data with?](#whydowe)
13. [Do we transfer personal data Overseas?](#dowetran)
14. [Third-party links](#thirdparty)
15. [Marketing](#link1)
16. [How to withdraw consent](#howtowith)
17. [Do we use automated decision-making or profiling?](#doweuse)
18. [How We Keep Your Personal Data Secure](#howwekeep)
19. [How to complain](#howtocom)

This document is provided in a layered format, using the headings set out above. If you are reading this online, please click on the numbers to be referred to the relevant section.

### Welcome

Welcome to Honeycomb Worldwide Inc.’s privacy notice, applicable to EEA and UK residents.

We appreciate the trust you place in us when sharing your personal data. We understand this is a big responsibility and the security of that data is very important to us. In this document, we will explain what information we collect, why and how we collect it, how we use it and how we protect your personal data.

We will also explain what rights you have regarding your personal data and how you can exercise those rights.

Please note that our website is not intended for children and we do not knowingly collect data relating to children.

### Who we are

We are Honeycomb Worldwide Inc. (hereafter referred to as “Honeycomb”, “we”, “us” or “our”) and are the parent company for Xtalks.

We are the data controller for ourselves and Xtalks, which means that we determine what personal data is collected by each organisation, how this personal data is going to be used and how this personal data is protected.

### Our EU and UK Representatives

We have appointed GRCI Law to act as our EU Representative. If you wish to exercise your rights under the EU General Data Protection Regulation (GDPR) or have any queries in relation to your rights or privacy matters generally please email [\[email protected\]](about:blank) or post your request or query to Head of Data Privacy Manager Service, GRCI Law Limited,  IT Governance Europe,  Third Floor, The Boyne Tower, Bull Ring, Lagavooren, Drogheda, Co. Louth, A92 F682.

We have appointed GRCI Law Limited to act as our UK Representative. If you wish to exercise your rights under the UK General Data Protection Regulation (GDPR), or have any queries in relation to your rights or privacy matters generally please email our Representative at [\[email protected\]](/cdn-cgi/l/email-protection#e0958b928590a0879283898c8197ce838f8d) or post your request or query to UK Representative, Unit 3, Clive Court, Bartholomew’s Walk, Cambridgeshire Business Park, Ely, Cambridgeshire, CB7 4EA, UK

When contacting our Representatives please ensure you include our company name in any correspondence.

### How to Contact Us

In addition to contacting our EU Representative, you can contact us at:

Honeycomb Worldwide Inc.

Name or title of data privacy manager: Andrew Juurinen

Email address: [**_\[email protected\]_**](about:blank)

Postal address: ATTN: Andrew Juurinen, 1235 Bay Street, Suite 802, Toronto, Ontario, M5R 3K4, Canada

or send us a message through our website at [**_https://xtalks.com/contact/_**](about:blank)

### What personal data we collect

We may collect, use, store and/or transfer different kinds of personal data about you. Personal data we collect includes:

- **Identity Data** includes first name, last name, username or similar identifier, marital status, title, date of birth, gender, employer, and job title.
- **Contact Data** includes billing address, address, email address and telephone numbers.
- **Resume Data** includes application materials and answers to screener questions given to employers through the Xtalks Job Platform and answers to any questionnaires. This information may be associated with a profile.
- **Transaction Data** includes details about payments and other details of products and services bought from us.
- **Technical Data** includes internet protocol (IP) address, login data, browser type and version, time zone setting and location, browser plug-in types and versions, operating system and platform and other technology on the devices used to access our website.
- **Profile Data** includes username and password, purchases or orders made, interests, preferences, feedback, and survey responses.
- **Images and personal appearance** include copies of passports or drivers’ licences.

- **Usage Data** includes information about how individuals use our website and services and online activity based on their interaction with us, our websites and applications for example searches, site visits browsing actions and patterns.
- **Marketing and Communications Data** includes preferences in receiving marketing from us and our third parties and communication preferences.
- **Publicly Available Data** includes identity and contact data from publicly available data sources such as Companies House and LinkedIn.

We do not collect any details about race or ethnicity, religious or philosophical beliefs, sex life, sexual orientation, political opinions, trade union membership, information about health or genetic and biometric data.

### Data Accuracy

It is important that the personal data we hold about you is accurate and current. Please keep us informed if your personal data changes during your relationship with us.

### How We Collect Your Personal Data

The data we collect depends on the context of your interactions with us and the choices that you make, including your privacy settings and the features that you use.

Most of the personal data that we collect about you will be information that you provide to us directly:

- when you register for an account with us and use our services
- when you register for a webinar, virtual event, or other content, host a webinar or take part in a webinar
- when you attend training with us
- when you fill in forms or correspond with us by post, phone, email or otherwise.
- When you subscribe to our service or publications
- when you take part in an event (e.g. as polling data, messaging, score cards, and other feedback)
- where you provide necessary information, e.g., for verification and billing purposes.
- when you take part in discussion boards or other forms of social media
- when you request marketing material to be sent to you
- when you enter a competition, promotion, or survey

We collect information through your behaviour and interactions with us:

- when you interact with our website, we may automatically collect technical data about your equipment, browsing actions and patterns. We collect this personal data by using cookies, server logs and other similar technologies
- from information from your device and actions taken on xtalks.com e.g., searches you run or webinars and jobs you click on
- when you apply to jobs or for webinars, use screener or assessment questions or log in from third party sites
- information we learn about you through our relationship and the way you interact with us

In some circumstances we may also receive information from:

- regulatory bodies
- other companies supplying services to us
- data analytics to improve our website, products/services, marketing, customer relationships and experiences
- publicly accessible social media networks such as Facebook, Instagram, LinkedIn, Google, and Twitter
- providers of technical, payment and delivery services
- publicly availably sources such as Companies House and LinkedIn

Click [here](about:blank) for more information about our use of cookies and how to disable them.

### Why We Use Your Personal Data

When we collect or otherwise process any personal information within the scope of European data protection laws, we do so where:

- necessary to provide our services, fulfil a transaction or otherwise perform a contract with you or at your request prior to entering into a contract
- it is in our legitimate interest to use personal information in such a way to ensure that we provide the our services in the best way that we can, protect the security of our systems, customers and website users and detect or prevent fraud,  wherever we process your personal data for these purposes, we ensure that your interests, rights and freedoms are carefully considered
- it is our legal obligation to use your personal information to comply with any legal obligations imposed upon us

Please contact us if you have any questions about how why we use your personal data.

### Your Rights

You have several rights under data protection laws, the rights available to you depend on our reason for processing your information and are set out below:

**Access** –the right to request a copy of the personal data we hold on you. In most cases, this will be free of charge, however in some limited circumstances, for example, repeated requests for further copies, we may apply an administration fee.

**Rectification of personal data** – this right enables you to have any incomplete or inaccurate data we hold about you corrected, though we may need to verify the accuracy of the new data you provide to us.

**Erasure of personal data** – You can ask us to delete or remove your personal information in some circumstances such as where there is no good reason for us continuing to process it.  We may not always be able to comply with your request of erasure for specific legal reasons which will be notified to you, job applicants  who submit their personal info through the job application portal may also need to contact the potential Employer to have this data deleted or requested.

**Restriction of processing personal data** – this enables you to ask us to suspend the processing of your personal data in the following scenarios: (a) if you want us to establish the data’s accuracy; (b) where our use of the data is unlawful but you do not want us to erase it; (c) where you need us to hold the data even if we no longer require it as you need it to establish, exercise or defend legal claims; or (d) you have objected to our use of your data but we need to verify whether we have overriding legitimate grounds to use it.

**Objection to processing of personal data** – you can ask us to stop processing your personal information, and we will do so, if we are relying on legitimate interests to process your personal information, except if we can show compelling legal grounds for the processing; or if we are processing your personal information for direct marketing purposes.

**Automated decision making** – you have the right to ask for a decision to be made manually, where a decision is made using automated means and this harmfully affects you.

**Portability** – you have the right to have personal data we hold about you transferred securely to another service provider in electronic form.

### How to exercise your rights

if you wish to exercise your rights or want further information about your rights please contact us.

In most circumstances you do not need to pay any charge for exercising your rights. We have 30 days to respond to you.

If you would like to unsubscribe from any email from us, you can also click on the ‘unsubscribe’ button at the bottom of the email or edit your subscription preferences [here](about:blank). It may take up to 7 days for this to take place.

### How long we hold your personal data

We will keep your personal data for no longer than is necessary to fulfil the purposes we collected it for, including for the purposes of satisfying any legal, accounting, or reporting requirements.

Job Applicant’s data when making job application is uploaded to Xtalks.com servers, then emailed directly to the potential Employer’s email address to which the job applicant applied. After transmission of the data is complete, the personal data is deleted from our servers.

We keep basic information about our customers and website users (including Contact, Identity, and Transaction Data) for no more than two years after they cease being customers or website users. We keep Financial Data of our customers for no more than six years after they cease being customers.

### Who do we share your personal data with?

We may from time to time share your personal data with the following organisations who also must keep your information confidential, safe, and secure:

1. potential Employers as part of a job application
2. service providers providing IT and system administration support and software services
3. payment Service providers such as PayPal Inc
4. third parties engaged in the course of the services we supply including webinar hosts
5. third party service providers to assist us with insight analytics, such as Google Analytics
6. third parties, employees, partners, agents, professionals, and subcontractors who supply products, services, and administrative support to us
7. law and law enforcement agencies, judicial bodies, credit reference agencies, fraud prevention agencies, governmental entities, tax authorities or government and regulatory bodies
8. where required as part of any proposed sale, reorganisation, transfer, financial arrangement, asset disposal or other transaction relating to our business and/or business assets
9. anyone else with your permission

(Please note this list is non-exhaustive and there may be other examples where we need to share with other parties to provide our services as effectively as we can).

### Do we transfer personal data Overseas?

Where necessary to deliver our services, we will transfer personal information to countries outside the EEA. In circumstances where personal data is transferred outside the EEA, we will only do so:

- where the transfer is to a country which has been assessed by the European Commission (or an equivalent UK body) as ensuring an adequate level of protection for personal data;
- with your consent; or
- where the transfer is compliant with the GDPR and other applicable laws.

### Third-party links

Our website may include links to third-party websites, plug-ins, and applications. Clicking on those links or enabling those connections may allow third parties to collect or share data about you. We do not control these third-party websites and are not responsible for their privacy statements. When you leave our website, we encourage you to read the privacy notice of every website you visit.

### Marketing

Our Company would like to send you information about products and services of ours that we think you might like.

You have the right at any time to stop us from contacting you for these purposes

please contact us If you no longer wish to be contacted for these purposes.

If you have opted out from our marketing communications, it is possible that your details may be recaptured through public sources in an unconnected marketing campaign. We will try to make sure this does not happen, but if it does, we are sorry, and we would ask that in those circumstances you opt out again. Where processing of data is based on your consent, you have the right to withdraw your consent to processing without affecting the lawfulness of processing based on consent before its withdrawal.

### How to withdraw consent

You can withdraw consent at any time where we are relying on consent to process your personal data. However, this will not affect the lawfulness of any processing carried out before you withdraw your consent. If you withdraw your consent, we may not be able to supply certain products or services to you. We will tell you if this is the case at the time you withdraw your consent.

### Do we use automated decision-making or profiling?

We do not use automated decision-making or profiling.

### How We Keep Your Personal Data Secure

We have put in place appropriate security measures to prevent your personal data from being accidentally lost, used or accessed in an unauthorised way, altered, or disclosed. In addition, we limit access to your personal data to those employees, agents, contractors and other third parties who have a business need to know. They will only process your personal data on our instructions, and they are subject to a duty of confidentiality.

### How to complain

You have the right to make a complaint at any time to the Information Commissioner’s Office (ICO), the UK supervisory authority for data protection issues ( [www.ico.org.uk](about:blank))  or if you wish to make a complaint to a different National Data Protection Authority please use this link to find  the appropriate contact details https:// edpb.europa.eu/about-edpb/board/members\_en

We would, however, appreciate the chance to deal with your concerns before you approach the ICO or another National Data Protection Authority so please [contact us](about:blank).

## **TERMS OF USE**

This notice details the Terms of Use for use of the website at www.Xtalks.com (hereafter referred to as “the Site”).  Users of the Site should read the Terms of Use in conjunction with the site’s **Privacy Policy**. The Site is owned and operated by Honeycomb Worldwide Inc. (hereafter referred to as “Honeycomb”, “we”, “us” or “our”).

By using the Site, you agree to be bound by the Site’s Terms of Use and accept our Privacy Policy. Please note that our Privacy Policy and Terms of Use may be updated or modified at any time without notice and your continued use of the Site will indicate your acceptance of the revised terms.

All rights to the content on the Site are reserved by Honeycomb. No part of the Site may be reproduced, stored in any retrieval system, or transmitted in any form – electronic, mechanical, photocopying, recording or otherwise – without prior consent from us. Such requests for consent should be forwarded to [\[email protected\]](/cdn-cgi/l/email-protection).

**Limitation of Liability**

While every care has been taken to ensure the data and information on the Site is accurate, we cannot accept, and hereby disclaim any liability to any party for loss or damage caused by errors or omissions resulting from negligence, accident or any other cause.

Further, neither the information on the Site nor the information provided during webinars or other events is business, legal or tax advice and should not be relied on as such.

**Third Party Materials**

Opinions and views expressed or implied on the Site are not necessarily those of Honeycomb and the company does not endorse any sponsors or advertisers, or their products or services, and accepts no responsibility for content provided by such parties.

The Site may include links to third party sites. We take no responsibility for the functionality of those links or the content posted on the third party sites to which you are redirected.

**Intellectual Property**

**©2004-2021 Honeycomb Worldwide Inc.**

All registered and unregistered trademarks on the Site are the sole property of their respective owners. Further, the content on the Site and provided during webinars and other events is subject to copyright, which is the property of its respective owners. We grant you a limited license to access and use the Site and its related content without reproducing elsewhere.

While presenters and sponsors retain IP rights over the content they present all webinars and videos produced by Xtalks are subject to Honeycomb’s copyright. For clarity, while sponsors and advertisers may deliver the same or similar content through other media channels (physical or online) it is expressly forbidden to replay or re-broadcast any Xtalks produced content on any other media, publishing or event industry website or platform without Honeycomb’s express written consent. Sponsors are hereby granted the permission to host the recordings of the webinars on their own website.

You agree that the words “Honeycomb Worldwide Inc.”, “Xtalks” or any variations thereof are trade names that are owned by Honeycomb, and any related marks are trademarks owned by Honeycomb. You specifically agree that you will never, in any way, use the words “Honeycomb”, “Xtalks” or any imitation or variant thereof as part of a trade name, company name, or firm name in a manner likely to cause customer confusion with Honeycomb’s services.

**Indemnification**

By using the Site, you accept to indemnify, defend and hold harmless Honeycomb, its directors, officers, employees and its affiliates from any claims, damages, liabilities and expenses, including legal fees, arising from your use of the Site and its related content, such as, but not limited to, hosted webinars and discussion forums. We reserve the right, at your expense, to assume the exclusive defense and control of any matter for which you are required to indemnify Honeycomb, and you agree to cooperate with our defense of these claims. You agree not to settle any matter without the prior consent of Honeycomb. We will use reasonable efforts to notify you of any such claim, action or proceeding upon becoming aware of it.

**Minors**

The Site is a business/industry professional website and is not targeted towards children or intended for use by children. Minors should not use the Site or register any information on the Site.

**Unauthorized Use**

When you register for access to the Site, or any elements of the Site such as webinars or discussion forums that may require additional or different registration criteria, you agree to only enter information about yourself that is both true and complete. You explicitly agree not to impersonate another person, such as one of our employees, hosts, editors or moderators. Similarly, you agree not to represent yourself as an employee or agent of any organization other than that which is true.

You agree not to post any information on the Site unless you have the legal right to post such content and by posting such content you are not infringing the legal rights of others. You agree that any content or comments you post on the Site will not be unlawful, threatening, abusive, libelous, defamatory, pornographic, or obscene.

You agree not to share unauthorized commercial communications on the Site and agree to adhere to all applicable anti-spam rules and regulations. You also agree not to collect any user content or information by any automated means.

**Unauthorized Access**

You will not share your account information with any other individual. You agree to keep confidential all account information that permit access to and enable use of the Site. You must notify us immediately of any breach of security or unauthorized use of your account. We will not be liable for any losses caused by any unauthorized use of your account.

**Content and Contact Information**

You are solely responsible for keeping your contact information current, accurate, complete and secure. We will not be held liable for your failure to do so. Further, we reserve the right to remove any content at any time.

**Termination**

We reserve the right, at any time, without notice and without reason, to cancel or terminate the account of any individual or refuse their current or future access. We may also terminate the account of any individual for violation of the Terms of Use. Upon termination, all rights granted to you will also terminate.

**Access**

Access to certain of the events, documents, articles or forums on the Site may be restricted. Registration does not guarantee your access to those items. This may be particularly true for certain webinars where the audience profile is defined by our partners. Webinar registrations should therefore be viewed as an application and not a guarantee of access to the content.

**No Warranty**

We do not warrant that the Site will be secure, error-free or function without disruption.

**Controlling Law and Severability**

The Terms of Use are governed by and construed in accordance with the laws of Ontario and the federal laws of Canada applicable therein. If for any reason a court of competent jurisdiction finds any provision, or portion thereof, to be unenforceable, the remainder of the Terms of Use shall continue to be in full force and effect.

AgreeDisagree

### Registration Successful

**Success! You're almost there. Check your email to access your Xtalks account password and instructions to reset it.**

Got your password? Login Here

**You must register for this webinar before messaging the presenter!**

[Register](https://xtalks.com/10-professionals-predict-the-future-of-clinical-trials-1967/#webinar-form-outer)

Copyright 2024 Honeycomb Worldwide Inc. All Rights Reserved. Site by [Trew Knowledge](http://trewknowledge.com).

We use functional cookies to improve your experience (e.g. view a video) and performance cookies to analyze site usage (e.g. pages visited). By clicking 'I agree' you consent. To customize, click 'privacy preferences'.

Privacy PreferencesI Agree

### Privacy Preference Center

Options

- Consent Management
- Cookie Settings
  - Strictly Necessary Cookies
  - Performance Cookies
  - Personalization

- [Privacy Policy](https://xtalks.com/privacy-policy-terms-of-use/)

#### Consent Management

You are asked to review the privacy policy upon initial login or after an update to the privacy policy.

Privacy Policy

Required

You read and agreed to our privacy policy.

#### Strictly Necessary Cookies

Cookies that are necessary for the site to function properly.

Cookies Used

Required

gdpr, wordpress, wordpress\_logged\_in, wordpress\_sec, wordpress\_test\_cookie, PHPSESSID, lc\_invitation\_opened, lc\_sso9058525, \_ga, \_gid, \_gat\_UA-39093340-1, \_ga\_MR38BSHE8Y, \_\_cf\_bm, \_gat\_gtag\_UA\_\*, \_gat\_UA-\*, \_ga\_\*, \_gat#, \_ga\_#, omSessionPageviews, omScrollHeight, omSessionStart, omVisitsFirst, gdprprivacy\_bar, tk\_rl, tk\_ro, \_gat\_gtag\_UA\_39093340\_1, \_GRECAPTCHA, om-ztcdnovyu5c7l82j2et5, omSeen-ztcdnovyu5c7l82j2et5, cf\_clearance

livechatinc.com

[Opt Out](https://www.livechatinc.com/privacy-policy/)

notification, main\_window\_timestamp, message\_text, \_\_livechat\_lastvisit, \_\_livechat, \_\_lc\_cst, \_\_lc\_mcid, \_\_lc\_mcst, 3rdparty, recent\_window, \_\_lc\_vv, chat\_running, @@lc\_auth\_token:453379f3-9bb6-47d9-8567-64f5f75f77a9, side\_storage\_453379f3-9bb6-47d9-8567-64f5f75f77a9, \_\_lc\_cid,

qzzr.com

[Opt Out](https://www.qzzr.com/cookie-policy)

\_\_cfduid, test, \_nid, \_utm, test

#### Performance Cookies

These are used to track user interaction and detect potential problems. These help us improve our services by providing analytical data of how users use this site.

Cookies Used

ONOFF

cmp, \_omappvp, \_omappvs, gdpr\[consent\_types\], gdpr\[allowed\_cookies\],

linkedin.com

[Opt Out](https://www.linkedin.com/legal/privacy-policy)

livechatinc.com

[Opt Out](https://www.livechatinc.com/privacy-policy/)

@@lc\_ids, 9058525:state,

#### Personalization

These are used to collect and store information about user interactions to improve ad selections

linkedin.com

[Opt Out](https://www.linkedin.com/legal/privacy-policy)

li\_sugr, bcookie, UserMatchHistory, AnalyticsSyncHistory, bscookie, lidc, li\_gc, \_\_oauth\_redirect\_detector, cmp475197507, FASID, \_fbp, tk\_or, tk\_tc, tk\_r3d, tk\_lr, #collect, \_livechat\_has\_visited, lastExternalReferrer, lastExternalReferrerTime, NID, prism\_475197507,

livechatinc.com

[Opt Out](https://www.livechatinc.com/privacy-policy/)

FASID

.youtube.com

[Opt Out](https://policies.google.com/privacy?hl=en-GB)

VISITOR\_INFO1\_LIVE, IDE, YSC

OK